Endocrinological aspects of bariatric surgery
- Authors: Troshina E.A.1, Ershova E.V.1, Mazurina N.V.1
-
Affiliations:
- Endocrinology Research Centre
- Issue: Vol 21, No 4 (2019)
- Pages: 50-55
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/96828
- DOI: https://doi.org/10.26442/20751753.2019.4.190336
- ID: 96828
Cite item
Full Text
Abstract
In the last decades all over the world surgical methods are used more widely for severe obesity treatment. A tendency is evident both in increase of the amount of operations and in increase of the number of countries where bariatric surgery becomes more widely spread. Indications and contraindications for bariatric surgery are presented in the guidelines including specific ones - in patients with type 2 diabetes mellitus (DM2). Different types of bariatric surgical interventions and mechanisms of influence on body mass, carbohydrate and lipid metabolism as well as main results in obese patients including ones with DM2 are described. The requirements for bariatric surgical interventions and parameters of their effectiveness estimation including DM2 remission are presented. The causes of postbariatric hypoglycemia and predictors of post-operation prognosis in relation to metabolic control in obese patients with DM2 are analyzed.
Full Text
##article.viewOnOriginalSite##About the authors
Ekaterina A. Troshina
Endocrinology Research Centre
Email: troshina@inbox.ru
Corr. Memb. RAS, D. Sci. (Med.) Moscow, Russia
Ekaterina V. Ershova
Endocrinology Research Centre
Email: yu99pol06@rambler.ru
Cand. Sci. (Med.) Moscow, Russia
Natalya V. Mazurina
Endocrinology Research Centre
Email: natalyamazurina@mail.ru
Cand. Sci. (Med.) Moscow, Russia
References
- Бондаренко И.З., Бутрова С.А., Гончаров Н.П. и др. Лечение морбидного ожирения. Национальные клинические рекомендации. Ожирение и метаболизм. 2018; 1: 53-70.
- Fried M, Yumuk V, Oppert J et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. International Federation for the Surgery of Obesity and Metabolic Disorders - European Chapter (IFSO - EC) and European Association for the Study of Obesity (EASO). Obes Surg 2014; 24 (1): 42-55.
- The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes. Ann Surg. 2010; 251 (3): 399-405.
- Яшков Ю.И., Ершова Е.В. «Метаболическая» хирургия. Ожирение и метаболизм. 2011; 3: 65-8.
- Flancbaum L. Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg 1999; 9 (6): 516-23.
- Buchwald H, Varco R. Metabolic Surgery. New York: Grune & Stratton, 1978.
- Дедов И.И., Яшков Ю.И., Ершова Е.В. Инкретины и их влияние на течение сахарного диабета 2 типа у пациентов с морбидным ожирением после бариатрических операций. Ожирение и метаболизм. 2012; 2: 3-10.
- Ершова Е.В., Яшков Ю.И. Состояние углеводного и липидного обмена у пациентов с ожирением и сахарным диабетом 2 типа после билиопанкреатического шунтирования. Ожирение и метаболизм. 2013; 3: 28-36.
- Яшков Ю.И., Никольский А.В., Бекузаров Д.К. и др. Cемилетний опыт применения операции билиопанкреатического отведения в модификации Hess-Marceau в лечении морбидного ожирения и сахарного диабета 2 типа. Ожирение и метаболизм. 2012; 2: 43-8.
- Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 249-61.
- Buse J, Caprio S, Cefalu W et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-5.
- Drucker D. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007; 117: 24-32.
- Holst J, Vilsboll T, Deacon C. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 2009; 297: 127-36.
- Mason E. The mechanism of surgical treatment of type 2 diabetes. Obes Surg 2005; 15: 459-61.
- Nauck M. Unraveling the science of incretin biology. Am J Med. 2009; 122: S3-S10.
- Rubino F, Gagner M. Potencial of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554-9.
- https://www.idf.org/
- Patti M, Goldfine A. Hypoglycaemia following gastric bypass surgery: diabetes remission in the extreme? Diabetologia 2010; 53: 2276-9.
- Rabiee A, Magruder J, Salas-Carrillo R et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: Unraveling the roles of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 2011; 167: 199-205.
- Heber D, Greenway F, Kaplan L et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95 (11): 4823-43.
- Pories W, Dohm G. Full and Durable Remission of Type 2 Diabetes? Through Surgery? Surg Obes Relat Dis 2009; 5 (2): 285-8.
